LONDON (Alliance News) - Biology company Physiomics PLC Monday said a presentation being given this week at a cancer conference is showing that the company's virtual tumour clinical programme correctly ranked different clinical regimens from literature.
Its part of the ongoing development of the platform.
The company's shares were down 2.7% at 0.18 pence Monday morning.
By Steve McGrath; stevemcgrath@alliancenews.com; @SteveMcGrath1
Copyright Β© 2013 Alliance News Limited. All Rights Reserved.


(Sharecast News) - Physiomics said on Friday that it was making strong operational progress and building the largest commercial pipeline in its histor...


(Sharecast News) - Physiomics said on Friday that it was making strong operational progress and building the largest commercial pipeline in its histor...


(Alliance News) - Physiomics PLC on Friday said it "continues to make strong operational progress" but noted one-off costs from the dismissal of its p...